Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
FARRAGUT PARTNERS ON BEHALF OF GENENTECH via WALTER CONSULTING
2016 · fourth_quarter · 4T
General health care issues
Filing targets: SENATE
FARRAGUT PARTNERS ON BEHALF OF GENENTECH via WALTER CONSULTING
2016 · third_quarter · Q3
Source: Senate LDA
| BOSTON SCIENTIFIC CORPORATION |
| 17 |
| 2005–2010 |
| NATIONAL ASSOCIATION OF REALTORS | 14 | 2006–2010 |
| ASC ADVOCACY COMMITTEE | 12 | 2009–2011 |
| NXSTAGE MEDICAL, INC. | 12 | 2007–2009 |
| GILEAD SCIENCES, INC. | 11 | 2014–2016 |
| THE MCMANUS GROUP ON BEHALF OF CARIS LIFE SCIENCES AND BREATHE TECHNOLOGIES INC. | 10 | 2008–2015 |
| FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE | 5 | 2016 |
| FARRAGUT PARTNERS ON BEHALF OF HERON THERAPEUTICS | 5 | 2016 |
| FARRAGUT PARTNERS ON BEHALF OF GENENTECH | 4 | 2016 |
| FARRAGUT PARTNERS ON BEHALF OF ASTRA ZENECA | 3 | 2016 |
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Cancer Care Payment Reform Act of 2015
Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE · Firm: WALTER CONSULTING
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement
Cancer Care Payment Reform Act of 2015
Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE · Firm: WALTER CONSULTING
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Cancer Care Payment Reform Act of 2015
Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE · Firm: WALTER CONSULTING
H.R.1934- Cancer Care Payment Reform Act Alternative payment models Medicare Part B reimbursement
Cancer Care Payment Reform Act of 2015
Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE · Firm: WALTER CONSULTING
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Cancer Care Payment Reform Act of 2015
Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE · Firm: WALTER CONSULTING
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
Comprehensive Addiction and Recovery Act of 2015
Client: GILEAD SCIENCES, INC. · Firm: WALTER CONSULTING
Coverage and reimbursement policy for HCV and HIV portfolio S.524/H.R.953-The Comprehensive Addiction and Recovery Act (CARA)
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Cancer Care Payment Reform Act of 2016
Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE · Firm: WALTER CONSULTING
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Cancer Care Payment Reform Act of 2016
Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE · Firm: WALTER CONSULTING
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Cancer Care Payment Reform Act of 2016
Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE · Firm: WALTER CONSULTING
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
Comprehensive Addiction and Recovery Act of 2016
Client: GILEAD SCIENCES, INC. · Firm: WALTER CONSULTING
Coverage and reimbursement policy for HCV and HIV portfolio S.524/H.R.953-The Comprehensive Addiction and Recovery Act (CARA)
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act
Ambulatory Surgical Center Quality and Access Act of 2015
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/HR.2500-- Ambulatory Surgical Center Quality and Access Act of 2013 Electronic health records and meaningful use
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/HR2500- Ambulatory Surgical Center Quality and Access Act of 2013 Electronic Health Records and Meaningful Use
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/HR.2500-- Ambulatory Surgical Center Quality and Access Act of 2013
Research and Development Tax Credit Extension Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733- excluding customary prompt pay discounts from Medicare
Research and Development Tax Credit Extension Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution management HR905/S733- excluding customary prompt pay discounts from Medicare
Research and Development Tax Credit Extension Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution management HR905/S733-- excluding customary prompt pay discounts from Medicare
Research and Development Tax Credit Extension Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution management HR905/S733-- excluding customary prompt pay discounts from Medicare
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/HR2500- Ambulatory Surgical Center Quality and Access Act of 2013 Electronic Health Records and Meaningful Use
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/HR.2500-- Ambulatory Surgical Center Quality and Access Act of 2013
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/HR.2500-- Ambulatory Surgical Center Quality and Access Act of 2013 Electronic health records and meaningful use
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Advocacy of advance care planning; electronic advance directives S.2240-- Medicare Choices Empowerment and Protection Act
Medicare Choices Empowerment and Protection Act
Client: ADVAULT, INC. · Firm: WALTER CONSULTING
Advocacy of advance care planning; electronic advance directives S.2240-- Medicare Choices Empowerment and Protection Act
ExaSCALE Computing Leadership Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution management HR905/S733-- excluding customary prompt pay discounts from Medicare
ExaSCALE Computing Leadership Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution management HR905/S733- excluding customary prompt pay discounts from Medicare
ExaSCALE Computing Leadership Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733- excluding customary prompt pay discounts from Medicare
ExaSCALE Computing Leadership Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution management HR905/S733-- excluding customary prompt pay discounts from Medicare
Removing Barriers to Colorectal Cancer Screening Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013 HR 1070- The Removing Barriers to Colorectal Cancer Act of 2013
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013 HR 1070- The Removing Barriers to Colorectal Cancer Act of 2013
H.R. 3204: Drug Quality and Security Act
Research and Development Tax Credit Extension Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733- excluding customary prompt pay discounts from Medicare
Research and Development Tax Credit Extension Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement H.R.905/S.733-- excluding customary prompt pay discount from ASP; Drug shortages
Research and Development Tax Credit Extension Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement Drug Pedigree H.R.905/S.733-- excluding customary prompt pay discount from Medicare
Research and Development Tax Credit Extension Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733-- excluding customary prompt pay discount from Medicare
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
Coverage and reimbursement policy for ambulatory surgery centers S.1137--Ambulatory Surgical Center Quality and Access Act of 2013 Drug shortages; drug compounding
Ambulatory Surgical Center Quality and Access Act of 2013
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013 HR 1070- The Removing Barriers to Colorectal Cancer Act of 2013
ExaSCALE Computing Leadership Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733- excluding customary prompt pay discounts from Medicare
ExaSCALE Computing Leadership Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement Drug Pedigree H.R.905/S.733-- excluding customary prompt pay discount from Medicare
ExaSCALE Computing Leadership Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement H.R.905/S.733-- excluding customary prompt pay discount from ASP; Drug shortages
ExaSCALE Computing Leadership Act of 2013
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733-- excluding customary prompt pay discount from Medicare
Drug Safety Enhancement Act of 2011
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement H.R. 905/S.733-- Excluding customary prompt pay discounts from ASP Pharmaceutical pedigree anti-counterfeiting legislation-- H.R.1483, H.R.3026, S.1584 Drug Shortages Track and Trace legislation
Drug Safety Enhancement Act of 2011
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP policy generally Pharmaceutical Distribution Reimbursement H.R. 905/S.733-- Excluding customary prompt pay discounts from ASP Pharmaceutical pedigree anti-counterfeiting legislation-- H.R. 1483, H.R.3026 and S. 1584 Drug shortage issue
Ambulatory Surgical Center Quality and Access Act of 2011
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
Coverage and reimbursement policy for Ambulatory Surgery Centers H.R.2108/S.1173-- The Ambulatory Surgical Center Quality and Access Act of 2011 Drug Shortages
Ambulatory Surgical Center Quality and Access Act of 2011
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
Reimbursement for Ambulatory Surgery Centers H.R. 2108/S.1173-- The Ambulatory Surgical Center Quality and Access Act of 2011 Drug shortage issue
Ambulatory Surgical Center Quality and Access Act of 2011
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
Coverage and reimbursement policy for Ambulatory Surgery Centers H.R.2108/S.1173-- The Ambulatory Surgical Center Quality and Access Act of 20122 Drug Shortages
Ambulatory Surgical Center Quality and Access Act of 2011
Client: THE ASC ASSOCIATION · Firm: WALTER CONSULTING
Coverage and reimbursement policy for Ambulatory Surgery Centers H.R.2108/S.1173-- The Ambulatory Surgical Center Quality and Access Act of 2011 Drug shortages
Safeguarding America's Pharmaceuticals Act of 2011
Client: AMERISOURCEBERGEN CORPORATION · Firm: WALTER CONSULTING
ASP reimbursement policy Pharmaceutical distribution reimbursement H.R. 905/S.733-- Excluding customary prompt pay discounts from ASP Pharmaceutical pedigree anti-counterfeiting legislation-- H.R.1483, H.R.3026, S.1584 Drug Shortages Track and Trace legislation
Monitoring issues relating to pharmaceutical reimbursement and regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FARRAGUT PARTNERS ON BEHALF OF GENENTECH via WALTER CONSULTING
2016 · fourth_quarter · Q4
General health care issues
Filing targets: SENATE
FARRAGUT PARTNERS ON BEHALF OF ASTRA ZENECA via WALTER CONSULTING
2016 · fourth_quarter · 4T
General monitoring of health care legislative activity
Filing targets: SENATE
FARRAGUT PARTNERS ON BEHALF OF HERON THERAPEUTICS via WALTER CONSULTING
2016 · fourth_quarter · 4T
General FDA issues
Filing targets: HOUSE OF REPRESENTATIVES
FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE via WALTER CONSULTING
2016 · fourth_quarter · 4T
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2016 · fourth_quarter · 4T
Coverage and reimbursement policy related to HCV and HIV portfolios
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2016 · fourth_quarter · 4T
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2016 · fourth_quarter · 4T
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2016 · fourth_quarter · 4T
Policies promoting medical innovation
Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2016 · fourth_quarter · 4T
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FARRAGUT PARTNERS ON BEHALF OF GENENTECH via WALTER CONSULTING
2016 · third_quarter · RR
General health care legislative activity on pharmaceutical issues
FARRAGUT PARTNERS ON BEHALF OF ASTRA ZENECA via WALTER CONSULTING
2016 · third_quarter · Q3
General monitoring of health care legislative activity
Filing targets: SENATE
FARRAGUT PARTNERS ON BEHALF OF ASTRA ZENECA via WALTER CONSULTING
2016 · third_quarter · RR
General monitoring of health care legislation
FARRAGUT PARTNERS ON BEHALF OF HERON THERAPEUTICS via WALTER CONSULTING
2016 · third_quarter · Q3
General FDA issues
Filing targets: HOUSE OF REPRESENTATIVES
FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE via WALTER CONSULTING
2016 · third_quarter · Q3
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2016 · third_quarter · Q3
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2016 · third_quarter · Q3
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2016 · third_quarter · Q3
Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies
Policies promoting medical innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2016 · third_quarter · Q3
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2016 · third_quarter · Q3
Coverage and reimbursement policy related to HCV and HIV portfolios
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FARRAGUT PARTNERS ON BEHALF OF HERON THERAPEUTICS via WALTER CONSULTING
2016 · second_quarter · Q2
General FDA issues
Filing targets: HOUSE OF REPRESENTATIVES
FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE via WALTER CONSULTING
2016 · second_quarter · Q2
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2016 · second_quarter · Q2
Coverage and reimbursement policy for HCV and HIV portfolio S.524/H.R.953-The Comprehensive Addiction and Recovery Act (CARA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2016 · second_quarter · Q2
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2016 · second_quarter · Q2
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2016 · second_quarter · Q2
Policies promoting medical innovation
Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2016 · second_quarter · Q2
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FARRAGUT PARTNERS ON BEHALF OF HERON THERAPEUTICS via WALTER CONSULTING
2016 · first_quarter · Q1
General FDA issues
Filing targets: HOUSE OF REPRESENTATIVES
FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE via WALTER CONSULTING
2016 · first_quarter · Q1
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2016 · first_quarter · Q1
VA coverage and reimbursement of HCV therapies
Coverage and reimbursement policy for HCV and HIV portfolio
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2016 · first_quarter · Q1
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2016 · first_quarter · Q1
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2016 · first_quarter · Q1
Coverage and reimbursement policy for medical devices/THV
Policies promoting medical innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2016 · first_quarter · Q1
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2016 · first_quarter · 1T
Medical device excise tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FARRAGUT PARTNERS ON BEHALF OF HERON THERAPEUTICS via WALTER CONSULTING
2016 · first_quarter · RR
Coverage and payment for therapies
FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE via WALTER CONSULTING
2016 · first_quarter · RR
H.R.1934- Cancer Care Payment Reform Act Alternative payment models Medicare Part B reimbursement
GILEAD SCIENCES, INC. via WALTER CONSULTING
2015 · fourth_quarter · Q4
Coverage and reimbursement policy for HCV portfolio
VA coverage and reimbursement of HCV therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2015 · fourth_quarter · Q4
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2015 · fourth_quarter · Q4
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2015 · fourth_quarter · Q4
Policies promoting medical innovation
Coverage and reimbursement policy for medical devices/THV
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2015 · fourth_quarter · Q4
Pharmaceutical distribution management ASP reimbursement policy
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2015 · fourth_quarter · Q4
Medical device excise tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2015 · third_quarter · Q3
Encouraging the adoption of digital advance care plans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2015 · third_quarter · Q3
Policies promoting medical innovation
Coverage and reimbursement policy for medical devices/THV
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2015 · third_quarter · Q3
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2015 · third_quarter · Q3
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Pharmaceutical distribution management ASP reimbursement policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2015 · third_quarter · Q3
Medical device excise tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2015 · third_quarter · Q3
VA coverage and reimbursement of HCV therapies
Coverage and reimbursement policy for HCV portfolio
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2015 · second_quarter · Q2
Encouraging the adoption of digital advance care plans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2015 · second_quarter · Q2
HR 1453- The ASC Quality and Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2015 · second_quarter · Q2
Policies promoting medical innovation
Coverage and reimbursement policy for medical devices/THV
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2015 · second_quarter · Q2
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Pharmaceutical distribution management ASP reimbursement policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2015 · second_quarter · Q2
Medical device excise tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2015 · second_quarter · Q2
Coverage and reimbursement policy for HCV portfolio
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2015 · first_quarter · Q1
Coverage and reimbursement policy for HCV portfolio
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2015 · first_quarter · Q1
Encouraging the adoption of digital advance care plans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2015 · first_quarter · Q1
HR 1453- The ASC Quality and Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2015 · first_quarter · Q1
Policies promoting medical innovation
Coverage and reimbursement policy for medical devices/THV
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MCMANUS GROUP ON BEHALF OF CARIS LIFE SCIENCES AND BREATHE TECHNOLOGIES INC. via WALTER CONSULTING
2015 · first_quarter · 1T
Medicare coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2015 · first_quarter · Q1
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Pharmaceutical distribution management ASP reimbursement policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2015 · first_quarter · Q1
Medical device excise tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2014 · fourth_quarter · Q4
Advocacy of advance care planning; electronic advance directives S.2240-- Medicare Choices Empowerment and Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2014 · fourth_quarter · Q4
S.1137/HR.2500-- Ambulatory Surgical Center Quality and Access Act of 2013 Electronic health records and meaningful use
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2014 · fourth_quarter · Q4
Coverage and reimbursement policy for medical devices/THV
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MCMANUS GROUP ON BEHALF OF CARIS LIFE SCIENCES AND BREATHE TECHNOLOGIES INC. via WALTER CONSULTING
2014 · fourth_quarter · Q4
Medicare coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2014 · fourth_quarter · Q4
ASP reimbursement policy Pharmaceutical distribution management HR905/S733-- excluding customary prompt pay discounts from Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2014 · fourth_quarter · Q4
Medical device excise tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2014 · fourth_quarter · Q4
Coverage and reimbursement policy for HCV portfolio
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2014 · third_quarter · Q3
Coverage and reimbursement policy for HCV portfolio
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2014 · third_quarter · Q3
Advocacy of advance care planning; electronic advance directives S.2240-- Medicare Choices Empowerment and Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2014 · third_quarter · Q3
S.1137/HR2500- Ambulatory Surgical Center Quality and Access Act of 2013 Electronic Health Records and Meaningful Use
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2014 · third_quarter · Q3
Coverage and reimbursement policy for medical devices/THV
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MCMANUS GROUP ON BEHALF OF CARIS LIFE SCIENCES AND BREATHE TECHNOLOGIES INC. via WALTER CONSULTING
2014 · third_quarter · Q3
Medicare coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2014 · third_quarter · Q3
LIFO repeal
ASP reimbursement policy Pharmaceutical distribution management HR905/S733- excluding customary prompt pay discounts from Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2014 · third_quarter · Q3
Medical device excise tax repeal
Filing targets: SENATE
GILEAD SCIENCES, INC. via WALTER CONSULTING
2014 · third_quarter · RR
Monitoring legislative and regulatory landscape as it relates to pharmaceutical development and pricing
ADVAULT, INC. via WALTER CONSULTING
2014 · second_quarter · Q2
Advocacy of advance care planning; electronic advance directives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2014 · second_quarter · Q2
S.1137/HR.2500-- Ambulatory Surgical Center Quality and Access Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2014 · second_quarter · Q2
Coverage and reimbursement policy for medical device/THV
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE MCMANUS GROUP ON BEHALF OF CARIS LIFE SCIENCES AND BREATHE TECHNOLOGIES INC. via WALTER CONSULTING
2014 · second_quarter · Q2
Medicare coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2014 · second_quarter · Q2
ASP reimbursement policy Pharmaceutical distribution management HR905/S733-- excluding customary prompt pay discounts from Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2014 · second_quarter · Q2
Medical Device Excise Tax Repeal
Filing targets: SENATE
THE MCMANUS GROUP ON BEHALF OF CARIS LIFE SCIENCES AND BREATHE TECHNOLOGIES INC. via WALTER CONSULTING
2014 · first_quarter · Q1
Medicare coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MCMANUS GROUP ON BEHALF OF CARIS LIFE SCIENCES AND BREATHE TECHNOLOGIES INC. via WALTER CONSULTING
2014 · first_quarter · RA
Coverage and reimbursement policy for molecular diagnostics (Caris) and NIOV technologies (Breathe).
ADVAULT, INC. via WALTER CONSULTING
2014 · first_quarter · Q1
Advocacy of advance care planning; electronic advance directives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2014 · first_quarter · Q1
Coverage and reimbursement policy for medical devices/THV
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2014 · first_quarter · Q1
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2014 · first_quarter · Q1
ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733- excluding customary prompt pay discounts from Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2014 · first_quarter · Q1
Medical device excise tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2013 · fourth_quarter · Q4
Advocacy of advance care planning; electronic advance directives
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2013 · fourth_quarter · Q4
H.R. 3204: Drug Quality and Security Act
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013 HR 1070- The Removing Barriers to Colorectal Cancer Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2013 · fourth_quarter · Q4
Medical device excise tax repeal
Coverage and reimbursement policy for medical devices/THV
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2013 · fourth_quarter · Q4
ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733- excluding customary prompt pay discounts from Medicare
LIFO repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via WALTER CONSULTING
2013 · fourth_quarter · Q4
Medical device excise tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAULT, INC. via WALTER CONSULTING
2013 · third_quarter · Q3
Advocacy of advance care planning; electronic advance directives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ASC ASSOCIATION via WALTER CONSULTING
2013 · third_quarter · Q3
Drug shortages; drug compounding
S.1137/H.R.2500-- Ambulatory Surgical Center Quality and Access Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES CORPORATION via WALTER CONSULTING
2013 · third_quarter · Q3
Coverage and reimbursement policy for medical devices/THV
Medical device excise tax repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via WALTER CONSULTING
2013 · third_quarter · Q3
ASP reimbursement policy Pharmaceutical distribution reimbursement HR905/S733-- excluding customary prompt pay discount from Medicare
Pharmaceutical compounding legislation; track and trace
Filing targets: HOUSE OF REPRESENTATIVES, SENATE